These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30327620)

  • 1. Baclofen for the Treatment of Alcohol Use Disorder in Patients With Liver Cirrhosis: 10 Years After the First Evidence.
    Mosoni C; Dionisi T; Vassallo GA; Mirijello A; Tarli C; Antonelli M; Sestito L; Rando MM; Tosoni A; De Cosmo S; Gasbarrini A; Addolorato G
    Front Psychiatry; 2018; 9():474. PubMed ID: 30327620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Alcohol Use Disorder in Patients With Alcoholic Liver Disease.
    Murthy P; Shadakshari D; Mahadevan J; Chand PK
    J Clin Exp Hepatol; 2022; 12(6):1514-1526. PubMed ID: 36340303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of alcohol use disorders in patients with alcoholic liver disease.
    Addolorato G; Mirijello A; Barrio P; Gual A
    J Hepatol; 2016 Sep; 65(3):618-30. PubMed ID: 27155530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review and meta-analysis: Efficacy and safety of baclofen in patients with alcohol use disorder co-morbid liver diseases.
    Duan F; Zhai H; Liu C; Chang C; Song S; Li J; Cheng J; Yang S
    J Psychiatr Res; 2023 Aug; 164():477-484. PubMed ID: 37441998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of alcohol dependence in patients with liver disease.
    Addolorato G; Mirijello A; Leggio L; Ferrulli A; Landolfi R
    CNS Drugs; 2013 Apr; 27(4):287-99. PubMed ID: 23456576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review.
    Khan A; Tansel A; White DL; Kayani WT; Bano S; Lindsay J; El-Serag HB; Kanwal F
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):191-202.e1-4; quiz e20. PubMed ID: 26256464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and Treatment of Alcohol Use Disorder in Patients With End-Stage Alcoholic Liver Disease.
    Caputo F; Domenicali M; Bernardi M
    Hepatology; 2019 Jul; 70(1):410-417. PubMed ID: 30471136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows.
    Addolorato G; Vassallo GA; Mirijello A; Gasbarrini A
    Neurotherapeutics; 2020 Jan; 17(1):127-141. PubMed ID: 31713188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective.
    de Beaurepaire R; Sinclair JMA; Heydtmann M; Addolorato G; Aubin HJ; Beraha EM; Caputo F; Chick JD; de La Selle P; Franchitto N; Garbutt JC; Haber PS; Jaury P; Lingford-Hughes AR; Morley KC; Müller CA; Owens L; Pastor A; Paterson LM; Pélissier F; Rolland B; Stafford A; Thompson A; van den Brink W; Leggio L; Agabio R
    Front Psychiatry; 2018; 9():708. PubMed ID: 30662411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.
    Addolorato G; Leggio L; Ferrulli A; Cardone S; Vonghia L; Mirijello A; Abenavoli L; D'Angelo C; Caputo F; Zambon A; Haber PS; Gasbarrini G
    Lancet; 2007 Dec; 370(9603):1915-22. PubMed ID: 18068515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baclofen Combined With Psychosocial Care is Useful and Safe in Alcohol-Related Cirrhosis Patients: A Real-Life Multicenter Study.
    Barrault C; Alqallaf S; Lison H; Lamote-Chaouche I; Bourcier V; Laugier J; Thevenot T; Labarriere D; Ripault MP; Le Gruyer A; Costentin C; Behar V; Hagege H; Jung C; Cadranel JF;
    Alcohol Alcohol; 2023 Mar; 58(2):117-124. PubMed ID: 36527321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: Controversies in Pharmacological Therapy.
    Tarli C; Mirijello A; Addolorato G
    Semin Liver Dis; 2022 May; 42(2):138-150. PubMed ID: 35292951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trial.
    Morley KC; Leung S; Baillie A; Haber PS
    Contemp Clin Trials; 2013 Nov; 36(2):348-55. PubMed ID: 23939511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: Results from a systematic review and meta-analysis.
    Gratacós-Ginès J; Bruguera P; Pérez-Guasch M; López-Lazcano A; Borràs R; Hernández-Évole H; Pons-Cabrera MT; Lligoña A; Bataller R; Ginès P; López-Pelayo H; Pose E
    Hepatology; 2024 Feb; 79(2):368-379. PubMed ID: 37625154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acamprosate may be safer than baclofen for the treatment of alcohol use disorder in patients with cirrhosis: a first description of use in real-world clinical practice.
    Tyson LD; Cheng A; Kelleher C; Strathie K; Lovendoski J; Habtemariam Z; Lewis H
    Eur J Gastroenterol Hepatol; 2022 May; 34(5):567-575. PubMed ID: 35421022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of baclofen in the treatment of alcohol-dependent patients.
    Addolorato G; Leggio L
    Curr Pharm Des; 2010; 16(19):2113-7. PubMed ID: 20482507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis.
    Rogal S; Youk A; Zhang H; Gellad WF; Fine MJ; Good CB; Chartier M; DiMartini A; Morgan T; Bataller R; Kraemer KL
    Hepatology; 2020 Jun; 71(6):2080-2092. PubMed ID: 31758811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baclofen in the Treatment of Patients With Alcohol Use Disorder and Other Mental Health Disorders.
    Agabio R; Leggio L
    Front Psychiatry; 2018; 9():464. PubMed ID: 30323774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
    Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
    Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of baclofen in maintenance of alcohol abstinence in patients with alcohol dependence and alcoholic hepatitis with or without cirrhosis.
    Yamini D; Lee SH; Avanesyan A; Walter M; Runyon B
    Alcohol Alcohol; 2014; 49(4):453-6. PubMed ID: 24939964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.